Travoton-T Eye Drops

Travoton-T Eye Drops

Travoton-T is an antiglaucoma ophthalmic formulation containing Travoprost and Timolol Maleate. The combination provides complementary mechanisms for lowering elevated intraocular pressure (IOP) and may be prescribed in the management of open-angle glaucoma and ocular hypertension.

Travoprost is a prostaglandin analogue that lowers intraocular pressure primarily by increasing the outflow of aqueous humour through the trabecular and uveoscleral pathways.

Timolol is a non-selective beta-adrenergic blocker that helps reduce the formation of aqueous humour, thereby contributing to the reduction of intraocular pressure.

The combination of Travoprost and Timolol provides complementary IOP-lowering effects. Fixed-dose Travoprost/Timolol ophthalmic combinations are used for adults with open-angle glaucoma or ocular hypertension when additional IOP reduction is required. 

Composition

Travoprost

Timolol Maleate

Uses of Travoton-T Eye Drops

Travoton-T Eye Drops may be prescribed for:

• Open-angle glaucoma
• Ocular hypertension
• Reduction of elevated intraocular pressure
• Reduction of intraocular pressure when treatment with a single antiglaucoma medicine is insufficient
• Long-term management of elevated IOP under ophthalmic supervision

The exact indication and treatment regimen should be determined by a qualified ophthalmologist.

How Travoton-T Works

Travoprost lowers intraocular pressure by increasing the drainage of aqueous humour from the eye.

Timolol lowers intraocular pressure by reducing the production of aqueous humour.

By acting through different mechanisms, the two components provide complementary pressure-lowering effects.

Key Product Features

• Travoprost + Timolol Maleate ophthalmic combination
• Dual-mechanism antiglaucoma formulation
• Helps reduce elevated intraocular pressure
• Used in the management of open-angle glaucoma
• Used for ocular hypertension
• Ophthalmic eye drop formulation
• 2.5 ml presentation

Product Information

Brand Name: Travoton-T

Composition: Travoprost & Timolol Maleate

Dosage Form: Ophthalmic Solution / Eye Drops

Route of Administration: Ophthalmic

Therapeutic Class: Antiglaucoma Ophthalmic Preparation

Pharmacological Class: Prostaglandin Analogue + Beta-Adrenergic Blocker

Packing: 2.5 ml

Important Information

Travoton-T Eye Drops are prescription ophthalmic medicine and should be used under the supervision of a qualified ophthalmologist.

Use the product exactly as prescribed. Do not change the frequency or discontinue treatment without medical advice.

The dropper tip should not touch the eye, eyelids, fingers or other surfaces to prevent contamination.

Timolol is a beta-blocker and may have systemic effects. Patients should inform their healthcare professional about existing heart, breathing or other medical conditions before use.

Patients using contact lenses should follow the instructions provided by their ophthalmologist or product label regarding lens removal and reinsertion.

If severe eye irritation, eye pain, sudden vision changes, allergic symptoms or other concerning reactions occur, seek medical attention.

Dosage and Administration

Use Travoton-T Eye Drops exactly as directed by the prescribing ophthalmologist.

The frequency and duration of treatment depend on the patient's intraocular pressure, diagnosis and clinical response.

Do not use more frequently than prescribed.

When more than one ophthalmic medicine is being used, an appropriate interval between different eye drops should be maintained as directed by the healthcare professional.

Storage

Store according to the storage conditions specified on the approved product label.

Keep the container tightly closed when not in use.

Protect from excessive heat, moisture and direct light where applicable.

Keep out of reach of children.

Product Summary

Travoton-T combines Travoprost and Timolol Maleate in an ophthalmic formulation designed to reduce elevated intraocular pressure.

By increasing aqueous humour outflow and reducing aqueous humour production, the two components provide complementary IOP-lowering activity for the management of selected glaucoma and ocular hypertension cases under ophthalmic supervision.